PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Recep Tayyip Erdogan University Training & Research Hospital, Rize, Turkey.\', \'Department of Medical Oncology, HSU Dr Abdurrahman Yurtaslan Oncology Training & Research Hospital, Ankara, Turkey.\', \'Department of Medical Oncology, HSU Diskapi Yildirim Beyazit Training & Research Hospital, Ankara, Turkey.\', \'Department of Medical Oncology, Gazi University, Ankara, Turkey.\', \'Department of Infectious Diseases & Clinical Microbiology, Gazi University, Ankara, Turkey.\', \'Department of Medical Oncology, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey.\', \'Department of Medical Microbiology, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey.\', \'Department of Medical Oncology, HSU Gulhane Training & Research Hospital, Ankara, Turkey.\', \'Department of Medical Oncology, A Life Hospital, Ankara, Turkey.\', \'Department of Preventive Oncology, Institute of Oncology, Hacettepe University, Ankara, Turkey.\', \'Department of Medical Oncology, Batman Training & Research Hospital, Batman, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2217/fon-2021-0597
?:hasPublicationType
?:journal
  • Future oncology (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34342517
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all